FDA:

Alexander G Yearley1, Caroline M W Goedmakers2, Armon Panahi3

  • 1Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA; Computational Neuroscience Outcomes Center (CNOC), Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.

PubMed
概括

食品和药物管理局 (FDA) 对中枢神经系统 (CNS) 人工智能 (AI) 算法的批准可能无法保证临床使用,因为神经算法的证据往往有限. 需要改善监管框架,以弥合人工智能批准和现实应用之间的差距.